当前位置:首页 - 行情中心 - 海辰药业(300584) - 财务分析 - 利润表

海辰药业

(300584)

27.61

0.04  (0.15%)

流通市值:132.37亿  总市值:330.84亿
流通股本:4.80亿   总股本:12.00亿

集合

竞价

利润表

按照会计年度查询:
报告期2018-12-312018-09-302018-06-302018-03-31
一、营业总收入711,907,833.07525,624,011.16341,423,225.17163,600,239.67
营业收入711,907,833.07525,624,011.16341,423,225.17163,600,239.67
二、营业总成本617,874,043.35455,170,269.88295,464,003.79143,973,979.96
营业成本98,049,788.8772,390,726.1447,788,786.5125,016,792.42
营业税金及附加12,707,116.169,389,439.475,975,671.442,906,130.21
销售费用437,956,033.73326,468,269.65208,869,361.1105,863,635.25
管理费用26,558,809.4920,780,422.2231,288,330.979,403,087.52
财务费用3,556,125.862,184,616.03931,124.74288,105.36
资产减值损失1,512,062.41410,800.96610,729.03496,229.2
三、其他经营收益--------
允许价值变动净收益--------
投资净收益1,221,017.341,030,121.15705,525.48414,093.72
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润96,516,866.5672,415,617.7847,275,476.3520,640,353.43
营业外收入293,091.21248,291.95246,401.9272,032.3
营业外支出840,825.78555,002.19151,519.1129,019.29
非流动资产处置净损失--------
五、利润总额95,969,131.9972,108,907.5447,370,359.1620,683,366.44
所得税12,745,920.199,812,379.646,661,193.933,696,664.01
未确认的投资损失--------
六、净利润(百万元)22.2783.2262.340.71
少数股东损益--------
归属于母公司股东的净利润83,223,211.862,296,527.940,709,165.2316,986,702.43
七、每股收益0.690.520.34--
基本每股收益0.690.520.340.21
稀释每股收益0.690.520.340.21
TOP↑